Literature DB >> 8900209

Protein kinase C alters the responsiveness of adenylyl cyclases to G protein alpha and betagamma subunits.

G Zimmermann1, R Taussig.   

Abstract

The ability of protein kinase C (PKC) to regulate the responsiveness of adenylyl cyclase to different activators was assessed. Membranes prepared from Sf9 cells infected with recombinant baculoviruses encoding either type II or IV adenylyl cyclase were incubated with recombinant PKCalpha (purified from Sf9 cells), and the effects on adenylyl cyclase activity were measured after reconstitution with Gsalpha, Gbetagamma, or forskolin. PKCalpha treatment of type II adenylyl cyclase leads to increases in basal, forskolin-stimulated, and betagamma-stimulated activities and greater sensitivity to stimulation by Gsalpha. Paradoxically, most of the betagamma potentiation of Gsalpha-stimulated activity is eliminated by pretreatment with PKCalpha. By contrast, treatment of type IV adenylyl cyclase with PKCalpha has little effect on the basal, forskolin-stimulated, or betagamma-stimulated activities but markedly reduces the Gsalpha-stimulated and betagamma-potentiated activity of this isoform. These studies demonstrate that protein kinases can alter both the activity of adenylyl cyclase isoforms and their responsiveness to G protein regulation, thereby altering the ability of adenylyl cyclases to integrate signals derived from multiple hormonal inputs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900209     DOI: 10.1074/jbc.271.43.27161

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling.

Authors:  S Chakrabarti; M Oppermann; A R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Cellular localisation of adenylyl cyclase: a post-genome perspective.

Authors:  Ferenc A Antoni; Ulrich K Wiegand; Jamie Black; James Simpson
Journal:  Neurochem Res       Date:  2006-02       Impact factor: 3.996

3.  Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.

Authors:  Ester Schallmach; Debora Steiner; Zvi Vogel
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis.

Authors:  J S Fine; H D Byrnes; P J Zavodny; R W Hipkin
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

5.  Regulation and immunohistochemical localization of betagamma-stimulated adenylyl cyclases in mouse hippocampus.

Authors:  L P Baker; M D Nielsen; S Impey; B M Hacker; S W Poser; M Y Chan; D R Storm
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

6.  Cross talk between beta-adrenergic and bradykinin B(2) receptors results in cooperative regulation of cyclic AMP accumulation and mitogen-activated protein kinase activity.

Authors:  S Hanke; B Nürnberg; D H Groll; C Liebmann
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  A compartmentalized mathematical model of the β1-adrenergic signaling system in mouse ventricular myocytes.

Authors:  Vladimir E Bondarenko
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

8.  Spinal adenosine A2(A) receptor inhibition enhances phrenic long term facilitation following acute intermittent hypoxia.

Authors:  M S Hoffman; F J Golder; S Mahamed; G S Mitchell
Journal:  J Physiol       Date:  2009-11-09       Impact factor: 5.182

9.  Molecular mechanisms underlying a cellular analog of operant reward learning.

Authors:  Fred D Lorenzetti; Douglas A Baxter; John H Byrne
Journal:  Neuron       Date:  2008-09-11       Impact factor: 17.173

10.  MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling.

Authors:  Emmanuel George Vrotsos; Kiminobu Sugaya
Journal:  Cell Mol Neurobiol       Date:  2008-12-02       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.